Location - PHYSIOFIRM
Key figures - PHYSIOFIRM
Turnover
For more information, please log inOperating income
For more information, please log inNet profit
For more information, please log inActivities - PHYSIOFIRM
Other classifications (for some countries)
NAF Rev.2 (FR 2008) : Continuing education for adults (8559A)
Conventions Collectives : AKTO - Convention collective nationale des organismes de formation (1516)
NACE Rev.2 (EU 2008) : Other education n.e.c. (8559)
ISIC 4 (WORLD) : Other education n.e.c. (8549)
NACE Rev.2.1 (EU 2025) : Other education n.e.c. (8559)
Activities
Follow us - PHYSIOFIRM
| Discover more on our Website |
|---|
Kompass membership
| Kompass ID? | FR5828946 |
|---|
Legal information - PHYSIOFIRM
| Type | Headquarters |
|---|---|
| Year established | 2008 |
| Legal form | SAS, société par actions simplifiée |
| Activity (NAF08) | Continuing education for adults (8559A) |
| Corporate capital | 7,000 EUR |
| SIREN | 504 682 394 |
| SIRET (Siège) | 504 682 394 00029 |
| VAT no |
FR93 504682394 |
| No employees (address) | 0-9 Employees |
| No employees | 0-9 Employees |
Other Companies recommended by Kompass:
Looking for new B2B Leads ?
Purchase a Company list with the executives and contact details
You might also like:
Need help finding the right information ? Let us guide you to the best solutions !
I am looking for :
The shortest path to your future customers and suppliers
"I would recommend EasyBusiness to all sales teams."
Test EasyBusiness for 14 days for free
No payment or credit card required
All-in-one prospecting solution designed to improve your productivity
Find your next customer today! Your shortcut to faster, more targeted and successful lead generation
Register for free and turn reliable data into real business opportunities
Your data is used to recontact you or send you communications and may be processed by Kompass, for the purposes of legitimate interest (Article 6 1.f of the GDPR).
You may object to its processing by email: dpo@kompass.com.
Find out more: see our privacy policy.